Pharmalot… Pharmalittle… Good Morning
Make a commentBy Ed Silverman // September 8th, 2010 // 7:00 am
Hello, everyone, nice to see you again. A sunny day is dawning here on the Pharmalot corporate campus, where the short people are off to the schoolhouse for another year of adventure and, hopefully, a little learning. While we ponder the possibilities, please join us for another cup of stimulation and a quick scan of the news of the world. Hope your day goes well…
Glaxo Hires Goldman Sachs Banker as CFO (Reuters)
Business Confidence Is Higher In Pharma Sector (PharmaTimes)
Biovail And Valeant Merger To Increase Layoffs (The Globe & Mail)
Teva & Baxter Must Pay $365M To Man Infected With Hepatitis C (Ha’aretz)
Clinical Trials Initiated In South Korea Rose 150% Since 2006 (OutsourcingPharma)
Shanghai Pharma Plans $1.2B IPO (Reuters)
Glaxo And Lonza Sign Development Deal (Dow Jones)
Sun Pharma Can Proceed With Taro Pharma Takeover (Bloomberg News)
Leave a Comment
Subscribe
Comments feed for this post only.
Tags
Baxter Healthcare, Clinical Trials, GlaxoSmithKline, Hepatitis C, Lonza, Shanghai Pharmaceuticals, South Korea, Sun Pharmaceuticals, Taro Pharmaceuticals, Teva Pharmaceuticals